Alzheimer's disease & dementia

Trial begins of nasal vaccine for Alzheimer's disease

(HealthDay)—The first human clinical trial of a nasal vaccine to slow the progression of Alzheimer's disease is set to begin after nearly 20 years of research.

Diseases, Conditions, Syndromes

Ebola vaccine to begin human trials

The University of Oxford have begun recruiting for a Phase I trial to test an Ebola vaccine in human volunteers—with the first vaccinations having already taken place.

Vaccination

WHO looking forward to oral, nasal COVID vaccines

The World Health Organization's chief scientist said Tuesday she was looking forward to the "second generation" of COVID-19 vaccines, which could include nasal sprays and oral versions.

page 21 from 40